Healthcare may finally have struck a healthy balance between AI hype and AI reality, according to a report from impartial observers who are also, indirectly at least, healthcare AI stakeholders.

The Massachusetts senator is asking buyer Sycamore Partners for certain assurances, including that it won’t saddle the struggling pharmacy chain with even more debt and indiscriminately close retail locations. 

Ontario-based Andlauer Healthcare Group ships sensitive temperature-controlled products necessary for healthcare manufacturing and research. It has agreed to be acquired by the world’s largest courier, with the all-cash deal expected to close later this year. 

AI is making patient financial advisors of hospital administrators who used to work in revenue cycle management. 

In medicine’s next chapter, AI literacy will separate physician leaders from peer followers. 

The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.

AI may finally end the paper chase caused by prior authorization. Or it may worsen it. 

The two companies have been unable to assuage antitrust concerns raised by the Department of Justice. A magistrate will attempt to hammer out acceptable terms for the home healthcare merger at a conference scheduled for August.